Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study
Annals of Neurology · 2024-08 · 96 (2) · 302-305
DOI: 10.1002/ana.27009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 11.06.2024. Verfasst von Viktor Grut und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Herpesvirus 6, Human, Multiple Sclerosis, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet, the Visare Norr Fund, Northern County Councils' Regional Federation, the Research and Development Unit, Region Jämtland Härjedalen.
Abstract (Originalsprache)
Synergistic interactions between human herpesvirus 6A (HHV‐6A) and Epstein–Barr virus (EBV) are hypothesized in the etiopathogenesis of multiple sclerosis (MS). This study investigated if HHV‐6A and EBV seroreactivities interact regarding the risk of developing MS. Antibodies against viral antigens were analyzed in biobank samples from 670 individuals who later developed MS and matched controls. Additive interactions were analyzed. A significant interaction between HHV‐6A and EBNA‐1 seroreactivities was observed in study participants above the median age of 24.9 years (attributable proportion due to interaction = 0.45). This finding supports the hypothesis that HHV‐6A and EBV infections interact in MS development. ANN NEUROL 2024;96:302–305
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Infections and Cancer Epidemiology Division, German Cancer Research Center, Heidelberg, Germany.
ORCID-Profile: Viktor Grut, Martin Biström, Pernilla Stridh, Daniel Jons, Ingrid Kockum
Förderung
- Vetenskapsrådet
- the Visare Norr Fund, Northern County Councils' Regional Federation
- the Research and Development Unit, Region Jämtland Härjedalen
Zitieren
APA
Grut, V., Biström, M., Salzer, J., Stridh, P., Jons, D., Gustafsson, R., Huang, J., Bergström, T., Kockum, I., Waterboer, T., Olsson, T., & Sundström, P. (2024). Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study. Annals of Neurology, 96(2), 302-305. https://doi.org/10.1002/ana.27009
Vancouver
Grut V, Biström M, Salzer J, Stridh P, Jons D, Gustafsson R, et al. Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study. Annals of Neurology. 2024;96(2):302-305. doi:10.1002/ana.27009
BibTeX
@article{Grut2024,
author = {Grut, Viktor and Biström, Martin and Salzer, Jonatan and Stridh, Pernilla and Jons, Daniel and Gustafsson, Rasmus and Huang, Jesse and Bergström, Tomas and Kockum, Ingrid and Waterboer, Tim and Olsson, Tomas and Sundström, Peter},
title = {Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study},
journal = {Annals of Neurology},
year = {2024},
volume = {96},
number = {2},
pages = {302--305},
doi = {10.1002/ana.27009}
}
EUVIMED